Huntingtin’s spherical solenoid structure enables polyglutamine tract-dependent modulation of its structure and function
Ravi Vijayvargia,
Raquel Epand,
Alexander Leitner,
Tae-Yang Jung,
Baehyun Shin,
Roy Jung,
Alejandro Lloret,
Randy Singh Atwal,
Hyeongseok Lee,
Jong-Min Lee,
Ruedi Aebersold,
Hans Hebert,
Ji-Joon Song,
Ihn Sik Seong
Affiliations
Ravi Vijayvargia
Center for Human Genetic Research, Massachusetts General Hospital, Boston, United States; Department of Neurology, Harvard Medical School, Boston, United States
Raquel Epand
Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada
Alexander Leitner
Department of Biology, Institute of Molecular Systems Biology, Eidgenössische Technische Hochschule Zürich, Zurich, Switzerland
Tae-Yang Jung
Department of Biological Sciences, Cancer Metastasis Control Center, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea; Department of Biosciences and Nutrition, Karolinska Institute, Solna, Sweden; School of Technology and Health, KTH Royal Institute of Technology, Novum, Sweden
Baehyun Shin
Center for Human Genetic Research, Massachusetts General Hospital, Boston, United States; Department of Neurology, Harvard Medical School, Boston, United States
Roy Jung
Center for Human Genetic Research, Massachusetts General Hospital, Boston, United States; Department of Neurology, Harvard Medical School, Boston, United States
Alejandro Lloret
Center for Human Genetic Research, Massachusetts General Hospital, Boston, United States; Department of Neurology, Harvard Medical School, Boston, United States
Randy Singh Atwal
Center for Human Genetic Research, Massachusetts General Hospital, Boston, United States; Department of Neurology, Harvard Medical School, Boston, United States
Hyeongseok Lee
Department of Biological Sciences, Cancer Metastasis Control Center, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
Jong-Min Lee
Center for Human Genetic Research, Massachusetts General Hospital, Boston, United States; Department of Neurology, Harvard Medical School, Boston, United States
Ruedi Aebersold
Department of Biology, Institute of Molecular Systems Biology, Eidgenössische Technische Hochschule Zürich, Zurich, Switzerland; Faculty of Science, University of Zurich, Zurich, Switzerland
Hans Hebert
Department of Biosciences and Nutrition, Karolinska Institute, Solna, Sweden; School of Technology and Health, KTH Royal Institute of Technology, Novum, Sweden
Ji-Joon Song
Department of Biological Sciences, Cancer Metastasis Control Center, KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
Center for Human Genetic Research, Massachusetts General Hospital, Boston, United States; Department of Neurology, Harvard Medical School, Boston, United States
The polyglutamine expansion in huntingtin protein causes Huntington’s disease. Here, we investigated structural and biochemical properties of huntingtin and the effect of the polyglutamine expansion using various biophysical experiments including circular dichroism, single-particle electron microscopy and cross-linking mass spectrometry. Huntingtin is likely composed of five distinct domains and adopts a spherical α-helical solenoid where the amino-terminal and carboxyl-terminal regions fold to contain a circumscribed central cavity. Interestingly, we showed that the polyglutamine expansion increases α-helical properties of huntingtin and affects the intramolecular interactions among the domains. Our work delineates the structural characteristics of full-length huntingtin, which are affected by the polyglutamine expansion, and provides an elegant solution to the apparent conundrum of how the extreme amino-terminal polyglutamine tract confers a novel property on huntingtin, causing the disease.